SCHEMBL398872

SCHEMBL398872

COCOc1c(I)cc(C(=O)OC)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BPTF Q12830 1/20 0.56
TSHR P16473 2/20 0.46
KDM4E B2RXH2 2/20 0.43
TPMT P51580 2/20 0.42
MAPT P10636 2/20 0.41
CYP3A4 P08684 2/20 0.41
EGFR P00533 1/20 0.40
CNR2 P34972 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SLC29A1 Q99808 1/20 0.39
HPGD P15428 1/20 0.39
USP2 O75604 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28534372 0.84 TPMT (0.53) BPTFTSHRKDM4ETPMTMAPT
SCHEMBL402764 0.84 TSHR (0.50) TSHRKDM4ETPMTMAPTCYP3A4
SCHEMBL10205503 0.82 SMN1; SMN2 (0.53) TSHRKDM4EMAPTMEN1KMT2A
SCHEMBL3673306 0.81 MAPT (0.47) BPTFKDM4EMAPTEGFRMEN1
SCHEMBL3673307 0.81 MAPT (0.47) BPTFKDM4EMAPTEGFRMEN1
SCHEMBL23202788 0.81 EGFR (0.48) TSHRKDM4EMAPTCYP3A4EGFR
SCHEMBL16491070 0.80 EGFR (0.47) TSHRKDM4EMAPTCYP3A4EGFR
SCHEMBL400758 0.79 NOTUM (0.43) TSHRKDM4ETPMTMAPTCYP3A4
SCHEMBL14024231 0.77 TPMT (0.65) BPTFTSHRKDM4ETPMTMAPT
SCHEMBL31156176 0.76 MGLL (0.52) KDM4EMAPTEGFRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA BPTF 1724/4885TSHR 1411/4885KDM4E 2908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.